Partners

The Institute for Clinical and Experimental Medicine (IKEM) is the only clinical center in the Czech Republic combining the full spectrum of therapies for diabetes and cardiovascular diseases, from various types of pharmacotherapies and standard invasive interventions to transplantation therapy for organ failure (heart, liver, kidneys, pancreas, and pancreatic islets). Intensive clinical, experimental, and translational research is conducted in each of these areas. In experimental research, IKEM primarily focuses on the study of experimental pathophysiological and physiological models pertaining to cardiovascular diseases, transplantation, diabetology, obesitology, and kidney disease. Most experimental research activities are conducted at the Experimental Medicine Centre (EMC), which also serves as a base for postgraduate studies in molecular biology and genetics, physiology and pathophysiology, biochemistry and pathobiochemistry, and metabolic disorders. In 2018, the Research, Development, and Innovation Council of the Government of the Czech Republic ranked IKEM an outstanding Class A research organization based on a new methodology known as M17+.

The Institute of Physiology of the Czech Academy of Sciences (IPHYS) is a leading national biomedicine research institute. It focuses on examining basic biological mechanisms, from the molecular level to the entire body. These mechanisms play a role in the occurrence of serious diseases, namely diseases associated with ageing and obesity (neurodegenerative and cardiovascular diseases, diabetes), epilepsy, and inherited metabolic diseases. The results of the research conducted at IPHYS help improve preventive, diagnostic, and therapeutic methods in the fight against serious lifestyle diseases affecting the whole of society. Much research is conducted in collaboration with the partners of this project as well as with other institutions, and IPHYS enriches these joint efforts with its unique expertise, methods, and biomodels. The institute offers preclinical testing of potential drugs with support provided by Strategy AV21 of the Czech Academy of Sciences. It also educates university students and trains PhD students in its biomedicine programs. In 2019, IPHYS was one of the first research institutes in the Czech Republic to receive the European Commission’s prestigious HR Award for excellence in human resources management in the scientific environment.